IAN T. BOTHWELL - 09 Jun 2021 Form 4 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role
Chief Financial Officer, Director, 10%+ Owner
Signature
/s/ Ian Bothwell
Issuer symbol
OCEL
Transactions as of
09 Jun 2021
Net transactions value
-$39,750
Form type
4
Filing time
11 Jun 2021, 21:45:18 UTC
Previous filing
08 Jun 2021
Next filing
16 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCEL Common Stock Sale $7,350 -50,000 -0.03% $0.1470 148,488,726 09 Jun 2021 Direct
transaction OCEL Common Stock Sale $4,500 -30,000 -0.02% $0.1500 148,458,726 09 Jun 2021 Direct
transaction OCEL Common Stock Sale $7,100 -50,000 -0.03% $0.1420 148,408,726 10 Jun 2021 Direct
transaction OCEL Common Stock Sale $14,000 -100,000 -0.07% $0.1400 148,308,726 10 Jun 2021 Direct
transaction OCEL Common Stock Sale $5,400 -40,000 -0.03% $0.1350 148,268,726 11 Jun 2021 Direct
transaction OCEL Common Stock Sale $1,400 -10,000 -0.01% $0.1400 148,258,726 11 Jun 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.